packageEdaravone

edaravone

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Edaravone is used to treat amyotrophic lateral sclerosis, acting as a free radical scavenger. It is approved in some countries, though a marketing application for it in the European Union was withdrawn.

Summary written by glm-5.3-flash from Wikidata Q335099 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:edaravone
ATC codes:N07XX14
DrugBank:DB12243
PubChem CID:4021
ChEBI:31530
Wikidata:Q335099
formula:C10H10N2O
molar mass:174.203 g/mol (PubChem CID 4021)
logP:1.3 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown